Literature DB >> 11986434

Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up.

H Simon Schaaf1, Robert P Gie, Magdalene Kennedy, Nulda Beyers, Peter B Hesseling, Peter R Donald.   

Abstract

SETTING: The Western Cape Province of South Africa, an area with a high tuberculosis (TB) incidence, where initial multidrug resistance (MDR) among adult TB cases was 1.1% during 1992-1993.
OBJECTIVE: To determine the long-term prevalence of TB infection and disease in children in household contact with adults with MDR pulmonary TB, and to establish the efficacy of chemoprophylaxis in preventing disease in these children.
METHOD: Children <5 years old in contact with 73 MDR TB adults were evaluated. Disease was treated by prescribing at least 2 drugs to which the adult's strain was susceptible. The remaining children were classified as infected or noninfected and received chemoprophylaxis according to the index's strain susceptibility or were followed up and treated when indicated. All were followed up for 30 months.
RESULTS: At the initial evaluation 125 children were seen, median age 27.5 months. Of these, 119 were followed up. Fourteen (12%) had disease, 61 (51%) were infected only, and 44 (37%) were noninfected. By 30-month follow-up, 29 (24%) had developed disease and 64 (54%) were infected only. Four adult-child pair Mycobacterium tuberculosis isolates were compared by DNA fingerprinting; 3 were identical. All children who developed TB disease were clinically cured. Two (5%) of 41 children who received appropriate chemoprophylaxis and 13 (20%) of 64 who did not, developed TB during follow-up (odds ratio: 4.97).
CONCLUSION: The study confirms MDR TB transmission to childhood contacts. Seventy-eight percent of children were infected or developed disease. Appropriate chemoprophylaxis may prevent disease in these children.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986434     DOI: 10.1542/peds.109.5.765

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  53 in total

1.  Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis.

Authors:  Chuan-Chin Huang; Mercedes C Becerra; Roger Calderon; Carmen Contreras; Jerome Galea; Louis Grandjean; Leonid Lecca; Rosa Yataco; Zibiao Zhang; Megan Murray
Journal:  Am J Respir Crit Care Med       Date:  2020-10-15       Impact factor: 21.405

2.  Drug-resistant tuberculosis: pediatric guidelines.

Authors:  Navaneetha Pandian Poorana Ganga Devi; Soumya Swaminathan
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

Review 3.  Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis.

Authors:  A Fraser; M Paul; A Attamna; L Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

4.  Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis.

Authors:  Hamidah Hussain; Courtney M Yuen; Amyn A Malik; Meredith B Brooks; Sara Siddiqui; Junaid Fuad; Charles A Peloquin; Farhana Amanullah; Maria Jaswal; Mercedes C Becerra
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

5.  Why do child contacts of multidrug-resistant tuberculosis not come to the assessment clinic?

Authors:  K Zimri; A C Hesseling; P Godfrey-Faussett; H S Schaaf; J A Seddon
Journal:  Public Health Action       Date:  2012-09-21

6.  Decentralised care for the management of child contacts of multidrug-resistant tuberculosis.

Authors:  J A Seddon; A C Hesseling; R Dunbar; H Cox; J Hughes; K Fielding; P Godfrey-Faussett; H S Schaaf
Journal:  Public Health Action       Date:  2012-09-21

Review 7.  Newer Drugs for Tuberculosis Prevention and Treatment in Children.

Authors:  Ben J Marais
Journal:  Indian J Pediatr       Date:  2019-02-01       Impact factor: 1.967

8.  Tuberculosis Burden among Household Pediatric Contacts of Adult Tuberculosis Patients.

Authors:  Rajeshwar Dayal; Dipti Agarwal; Rakesh Bhatia; C Bipin; Neeraj Kumar Yadav; Santosh Kumar; Shamrendra Narayan; Ankur Goyal
Journal:  Indian J Pediatr       Date:  2018-03-20       Impact factor: 1.967

9.  Children and multidrug-resistant tuberculosis in Mumbai (Bombay), India.

Authors:  Sunil Karande; Sandeep B Bavdekar
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

10.  Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome.

Authors:  H S Schaaf; K Shean; P R Donald
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.